Lv11
32 积分 2024-01-23 加入
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
3小时前
已完结
Targeting APRIL in the treatment of glomerular diseases
3个月前
已完结
Regulatory T cells constrain T cells of shared specificity to enforce tolerance during infection
6个月前
已完结
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high
6个月前
已完结
Zinc-glutathione mitigates alcohol-induced intestinal and hepatic injury by modulating intestinal zinc-transporters in mice
6个月前
已完结
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
6个月前
已关闭
Concerted epithelial and stromal changes during progression of Barrett’s Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysis
7个月前
已完结
Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggest a limited set of immunodominant sarcoma antigens
7个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
7个月前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
7个月前
已完结
皖公网安备34019202002308
